Skip to main content
. 2016 Sep 22;6:33949. doi: 10.1038/srep33949

Figure 3.

Figure 3

Molecular interactions of gefitinib with selected human off-targets; (A) mutant EGFR kinase domain; (B) PIM- 1, (C) MAPK10; (D) CHEK1; (E) DHODH; (F) ERBB4; (G) CHK2 and (H) HSD17B1. PDB codes are shown in brackets. The H-bond and polar interactions are represented by black line and green lines respectively.